Long COVID relief through learning mindfulness

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with persistent symptoms of Post-Acute Sequelae of SARS-CoV-2 infection are randomly assigned to begin an 8-week series of recorded mindfulness sessions either immediately or after an 8-week waitlist period while continuing usual medical care. The intervention was developed specifically for people with PASC and is delivered remotely as structured recorded sessions. Outcomes (stress, PASC symptoms, and quality of life) are measured with four online surveys over six months. The trial excludes people already engaged in a structured mindfulness-based intervention or enrolled in another PASC intervention trial.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \> or = 18
* Willing and able to provide informed consent
* Access to the internet
* Self-reported history of SARS-CoV-2 infection
* Current symptoms attributed to PASC by participant or by participant's medical provider; ongoing symptoms that persisted \>= 12 weeks after Covid-19 illness

Exclusion Criteria:

* Participating in another clinical trial of an intervention for PASC symptoms
* Engaged in a structured MBI

Where it's running

• Columbia University
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Deborah Theodore, MD — Columbia University
• Study coordinator: Deborah Theodore, MD
• Email: dat2132@cumc.columbia.edu
• Phone: 2123058739

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating Anakinra for Long COVID Symptoms

  This study is testing if anakinra, an anti-inflammatory medication, can help people with long COVID symptoms feel better.

  Recruiting at 14 sites Phase 2/3 Hellenic Institute for the Study of Sepsis · Jena and 23 other locations · NCT05926505

• 2-HOBA to reduce persistent immune activation in Long COVID with POTS

  This trial will test whether 2‑HOBA, a compound that scavenges harmful IsoLG-adducts, can reduce immune activation in adults with Long COVID who have POTS.

  Recruiting Phase 2 Vanderbilt University Medical Center · Nashville, Tennessee · NCT07189936

• Mind-body intervention for people with Long COVID

  This study is testing a mind-body program to see if it can help people with Long COVID feel better and improve their daily activities.

  Recruiting Beth Israel Deaconess Medical Center · Boston, Massachusetts · NCT06045338

• Transcranial Direct Current Stimulation for Long COVID with Headaches and Chronic Pain

  This study tests whether applying mild brain stimulation (tDCS) can help people with long COVID who have headaches, migraines, and ongoing pain.

  Recruiting at 2 sites Fundación Universidad Católica de Valencia San Vicente Mártir · Paiporta, Valencia and 1 other locations · NCT05780450

• A study using wearable devices to manage Long COVID symptoms

  This study is testing if using wearable devices can help people with Long COVID manage their symptoms and improve their quality of life.

  Recruiting Scripps Translational Science Institute · La Jolla, California · NCT05741112

• A platform for collecting health data on ME/CFS and Long Covid

  This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.

  Recruiting Brain Inflammation Collaborative · Delafield, Wisconsin · NCT04806620

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.